StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.27+0.12 (+1.47%)

Close on Nov 18, 2026Market cap $288.48MP/E –Yield –

Benitec Biopharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Benitec Biopharma's pe ratio was 179.1× on Jul 31, 2020.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Jul 31, 2020179.1×−12.8
2019Dec 31, 2019191.9×–

More Benitec Biopharma figures

See a number that looks wrong?